Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -25.30M
March 31, 2026 -39.70M
December 31, 2025 -55.50M
September 30, 2025 -23.80M
June 30, 2025 -91.10M
March 31, 2025 -26.10M
December 31, 2024 -74.30M
September 30, 2024 -67.60M
June 30, 2024 -1.325B
March 31, 2024 -305.10M
December 31, 2023 -37.30M
September 30, 2023 -156.50M
June 30, 2023 -26.30M
March 31, 2023 -102.90M
December 31, 2022 -149.30M
September 30, 2022 -57.60M
June 30, 2022 57.10M
March 31, 2022 -101.80M
December 31, 2021 -48.60M
September 30, 2021 -48.40M
June 30, 2021 -71.40M
March 31, 2021 -24.00M
December 31, 2020 -28.80M
September 30, 2020 -48.20M
June 30, 2020 -15.10M
Date Value
March 31, 2020 -101.80M
December 31, 2019 -39.20M
September 30, 2019 -12.60M
June 30, 2019 -79.90M
March 31, 2019 -26.70M
December 31, 2018 -156.30M
September 30, 2018 -29.10M
June 30, 2018 -46.10M
March 31, 2018 108.10M
December 31, 2017 45.00M
September 30, 2017 47.30M
June 30, 2017 -51.20M
March 31, 2017 -71.30M
December 31, 2016 -40.30M
September 30, 2016 18.30M
June 30, 2016 6.90M
March 31, 2016 -7.40M
December 31, 2015 -43.60M
September 30, 2015 -37.30M
June 30, 2015 -15.80M
March 31, 2015 -5.70M
December 31, 2014 -66.20M
September 30, 2014 -52.90M
June 30, 2014 -74.90M
March 31, 2014 -7.90M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Revvity, Inc. -3.505M
Waters Corp. 2.00M
Agilent Technologies, Inc. -1.032B
Bio-Rad Laboratories, Inc. -66.70M
Danaher Corp. -10.15B